Recent Finacing
Recent Raise
Sutro Biopharma is a clinical-stage biopharma that uses proprietary cell-free protein synthesis and site-specific conjugation platforms (XpressCF/XpressCF+) to design, manufacture, and collaborate on ADCs, bispecifics, and cytokine-based oncology therapeutics.
